| Dendritic cell-based vaccine efficacy: aiming for hot spots GA Pizzurro, MM Barrio Frontiers in immunology 6, 91, 2015 | 83 | 2015 |
| Human macrophages and dendritic cells can equally present MART-1 antigen to CD8+ T cells after phagocytosis of gamma-irradiated melanoma cells MM Barrio, R Abes, M Colombo, G Pizzurro, C Boix, MP Roberti, E Gelize, ... PloS one 7 (7), e40311, 2012 | 76 | 2012 |
| Self-assembly of mesoscale collagen architectures and applications in 3D cell migration C Liu, RY Nguyen, GA Pizzurro, X Zhang, X Gong, AR Martinez, M Mak Acta biomaterialia 155, 167-181, 2023 | 22 | 2023 |
| Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma A Mittal, M Wang, A Vidyarthi, D Yanez, G Pizzurro, D Thakral, E Tracy, ... Scientific reports 11 (1), 10731, 2021 | 12 | 2021 |
| 3D model of the early melanoma microenvironment captures macrophage transition into a tumor-promoting phenotype GA Pizzurro, C Liu, K Bridges, AF Alexander, A Huang, JP Baskaran, ... Cancers 13 (18), 4579, 2021 | 11 | 2021 |
| Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine GA Pizzurro, IJ Tapia, L Sganga, OL Podhajcer, J Mordoh, MM Barrio Cancer Immunology, Immunotherapy 64, 1393-1406, 2015 | 11 | 2015 |
| Combinatorial immunotherapy with agonistic CD40 activates dendritic cells to express IL12 and overcomes PD-1 resistance I Krykbaeva, K Bridges, W Damsky, GA Pizzurro, AF Alexander, ... Cancer Immunology Research 11 (10), 1332-1350, 2023 | 8 | 2023 |
| Reframing macrophage diversity with network motifs GA Pizzurro, K Miller-Jensen Trends in Immunology, 2023 | 7 | 2023 |
| High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function GA Pizzurro, FP Madorsky Rowdo, LM Pujol-Lereis, LA Quesada-Allué, ... Cancer Immunology, Immunotherapy 62, 3-15, 2013 | 6 | 2013 |
| Functionally and metabolically divergent melanoma-associated macrophages originate from common bone-marrow precursors GA Pizzurro, K Bridges, X Jiang, A Vidyarthi, K Miller-Jensen, OR Colegio Cancers 15 (13), 3330, 2023 | 3 | 2023 |
| Abstract B48: CD40-agonist treatment can prime the inflammatory response of macrophages and reverse checkpoint inhibitor resistance in melanoma GA Pizzurro, K Bridges, S Kaech, M Bosenberg, K Miller-Jensen Cancer Immunology Research 10 (12_Supplement), B48-B48, 2022 | 1 | 2022 |
| Single-Cell Analysis Reveals a Subset of High IL-12p40–Secreting Dendritic Cells within Mouse Bone Marrow–Derived Macrophages Differentiated with M-CSF K Bridges, GA Pizzurro, M Khunte, M Chen, E Salvador Rocha, ... The Journal of Immunology 212 (8), 1357-1365, 2024 | | 2024 |
| Multiomics reveals age-dependent metabolic reprogramming of macrophages by wound bed niche secreted signals MF Forni, GA Pizzurro, WSW Krause, AF Alexander, K Bridges, Y Xu, ... bioRxiv, 2024.10. 30.621159, 2024 | | 2024 |
| Mapping intratumoral myeloid-T cell interactomes at single-cell resolution reveals targets for overcoming checkpoint inhibitor resistance K Bridges, GA Pizzurro, A Baysoy, JP Baskaran, Z Xu, V Mathew, ... bioRxiv, 2024.10. 28.620093, 2024 | | 2024 |
| CD40-agonist treatment can prime the inflammatory response of macrophages and reverse checkpoint inhibitor resistance in melanoma. GA Pizzurro, K Bridges, S Kaech, M Bosenberg, K Miller-Jensen CANCER IMMUNOLOGY RESEARCH 10 (12), 2022 | | 2022 |
| Desarrollo de vacunas terapéuticas con células dendríticas humanas para melanoma: optimización de parámetros fenotípicos y funcionales in vitro e in vivo de la vacuna … GA Pizzurro Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales, 2016 | | 2016 |
Kathryn Miller-JensenAssociate Professor of Biomedical Engineering, Yale University在 yale.edu 的电子邮件经过验证
